Poland· PL-100351280
Effortil
A etilefrine product containing etilefrini hydrochloridum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Etilefrine is registered in 8 of 19 countries.
Countries holding a registration under ATC C01CA01 (etilefrine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Etilefrine · ATC C01CA01
8 / 19 countries
- Belgiumprice
- Finlandprice
- Germany
- Japan
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of etilefrine costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Etilefrine · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.39
The record
At a glance
URPL (Poland)- Active substance
- Etilefrini hydrochloridum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- C01CA01
- ATC class
- Etilefrine
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991233129
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Etilefrine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandEffortil
- FinlandEffortilParanova Oy
- BelgiumEffortil 5 mgSERB
- GermanyBioflutinSuedmedica Gmbh
- FranceEFFORTIL 5 mg, compriméSERB
- United KingdomEffortil 5mg tabletsImported (Japan)
- SwedenEffortil 5 mg TablettSERB S.A.
- NorwayEffortilBoehringer Ingelheim
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Austria · Effortil
- Belgium · Effortil
- Germany · Bioflutin, Effortil
- Finland · Effortil
- France · Effortil, Etilefrine S.E.R.B.
- Italy · Effortil
- Luxembourg · Effortil
- Sweden · Effortil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2c9e2d77-c99a-476e-8b4e-f49d7ed76ac5 GET /v1/drugs/2c9e2d77-c99a-476e-8b4e-f49d7ed76ac5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople doustne",
"source": "urpl",
"strength": "7,5 mg/g",
"packaging": "05909991233129 ¦ Rp ¦ 110218\n1 butelka 15 g",
"substance": "Etilefrini hydrochloridum 7.5 mg/g",
"common_name": "Etilefrini hydrochloridum",
"pl_product_id": "100351280",
"pozwolenie_nr": "528/15",
"auth_procedure": "IR",
"authorisation_validity": "2030-08-06"
}See everything about etilefrine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.